Download presentation
Presentation is loading. Please wait.
1
Nat. Rev. Neurol. doi:10.1038/nrneurol.2017.88
Figure 3 Common problems with the interpretation of pharmacogenetic studies in CIPN Figure 3 | Common problems with the interpretation of pharmacogenetic studies in CIPN. Several methodological drawbacks of chemotherapy-induced neuropathy (CIPN) pharmacogenetic trial design should be improved in future studies, to enable the management of CIPN to be informed by genetic associations. GWAS, genome-wide association study; SNP, single nucleotide polymorphism. Argyriou A. A. et al. (2017) Chemotherapy-induced peripheral neurotoxicity: management informed by pharmacogenetics Nat. Rev. Neurol. doi: /nrneurol
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.